Wednesday, July 27
10:15 – 11:15 a.m.
Exhibit Hall Theater 3
Supported by T2 Biosystems
Culture-independent tests have shifted the paradigm in species identification for bloodstream infections. Current diagnostic tests for bloodstream infections have limited sensitivity and extended time to identification of sepsis causative pathogens. T2 Biosystems Panels detect sepsis-causing pathogens direct from whole blood. Faster identification of causative pathogens with T2 Biosystems Panels leads to positive clinical and economic outcomes in sepsis patients, including reduced length of hospital stay, improved savings in hospital costs, and improved antimicrobial/antifungal stewardship.
After attending this session, participants will be able to:
Aparna Ahuja, MD Chief Medical Officer T2Biosystems.com Lexington, MA
Thomas J. Walsh, MD, PhD Director Center for Innovative Therapeutics and Diagnostics
Denise Uettwiller-Geiger, PhD Mather Hospital
Be the first to get all the latest news.